Global Demand Outlook for Executive Summary Antisense Oligonucleotide for Neuromuscular Disorders Market Size and Share The global antisense oligonucleotide for neuromuscular disorders market size was valued at USD 2.03 billion in 2024 and is expected to reach USD 4.87 billion by 2032, at a CAGR of 11.50% during the forecast period. This Antisense...